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Escaping from, moving towards, following a path,
squeezing through: lots of opportunities for
moving cells
Paola Chiarugi
Eukaryotic cells move within the surrounding environ-
ment essentially for two reasons: the necessity to reach
a predetermined site or the hostility of the primitive
site. Moving in the direction of an attractive site or fac-
tor is typical for embryonic movements and metastatic
dissemination of cancer cells and motility strategies are
very similar for both categories. Activation of an epige-
netic process called epithelial mesenchymal transition
(EMT) is indeed characteristic of embryonic develop-
ment, of fibrotic or regeneration processes, and of the
spreading of cancer cells from their primitive origin
[1,2]. The most aggressive cancers have developed a
further program of cellular plasticity that is very useful
to adapt to particular environmental changes, i.e. the
mesenchymal amoeboid transition (MAT). This addi-
tional strategy is associated with the deregulation of
important oncosuppressor pathways and the hyperex-
pression of oncogenes, especially those linked to the
activation of the Rho GTPase family [3]. The choice of
migration styles enables cells to use ad hoc mesenchy-
mal or amoeboid modes of motility and grants to cells
of aggressive cancers the ability to move in environ-
ments with different structural characteristics using
either matrix proteases to degrade the extracellular
matrix (ECM) or squeezing between its gaps. This
adaptability of motility styles to the environment is cur-
rently considered to be the main reason for the failure
of clinical trials testing protease inhibitors in patients
with metastatic cancers. Brabek et al. [4] review in this
special issue the role of matrix stiffness and composition
for plasticity of cancer cell motility, while Parri and
Chiarugi [5] focus on the role of Rho GTPases for the
ad hoc switch between different motility strategies. The
interest of molecular biologis t si sp a r t i c u l a r l yf o c u s s e d
on this family of GTPases and their regulators as targets
for an effective antimetastatic therapy. Indeed, instead of
inhibiting a specific motility mechanism, it would be
preferable to target the adaptation skills of cancer cells
to the tumor microenvironment.
This microenvironment is indeed a mandatory element
for the regulation of cell motility [6]. Three key factors
are affecting the shift between modes of motility: stiffness
and composition of ECM (Brabek et al., this issue [4]),
intratumoral hypoxia [7] and the cellular stromal coun-
terpart of the tumor mass (Calorini and Bianchini, this
issue, [8]). The latter is composed of several cell types,
with fibroblasts, macrophages and endothelial cells being
the most relevant for tumor progression towards a
motile/aggressive phenotype. Calorini and Bianchini [8]
review the role of cancer associated fibroblasts and
macrophages while Brabek et al. focus on endothelial
cells [4]. Cancer-associated fibroblasts (CAFs) are
engaged in a bidirectional interplay with cancer cells [9].
CAFs secrete large amount of soluble factors affecting
tumor progression toward a more malignant and motile
phenotype. Indeed CAFs activate a pro-inflammatory
route [10], likely leading cancer cells to activate the EMT
motility program [11]. On the other hand, malignant
cells increase the expression of other soluble factors,
thereby leading to the “activation” of stromal fibroblasts.
These activated fibroblasts increase their contractility,
their secretion of large amount of ECM proteins (thereby
changing the ECM composition), as well as their secre-
tion of factors affecting the EMT of cancer cells. Cancer-
associated macrophages (CAMs) infiltrate the cancer
mass, being attracted by tumor secreting factors. CAMs
show several intermediate levels of activation in response
to these factors, although they all are of the M2-subtype,
that is incapable of killer and antigen presenting activ-
ities, but able to affect the malignancy and motility of
cancer cells [12].
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cell motility, for two reasons: the secretion of neuro-
transmitters which also act as motility factors and the
contribution of an alternative escaping way to migrating
cells, commonly called perineural invasion. In this spe-
cial issue Voss and Entschladen review this aspect with
a particular focus on the role of cathecolamine and
stress mediators on tumoral cell motility [13].
As mentioned at the beginning, a second reason for cells
to move is the escape from an hostile ambiente, for exam-
ple due to the scarcity of growth factors (chemotaxis), due
to the presence of improper ECM (aptotaxis and duro-
taxis), because of the accumulation of toxic or pro-oxidant
factors (escaping from primitive tumoral or inflamatory
sites) or to escape oxygen or nutrient deprivation (hypoxia
and ischemia). De Donatis et al. [14] focus their review on
the role of growth factor gradients as regulators of a
motile phenotype in which cells aim to reach a definite
growth factor concentration that is suitable for cell dupli-
cation. In this context, the motile and proliferative pheno-
types are mutually exclusive and the review of De Donatis
et al. clarifies the role of growth factor receptor clustering
and internalization in the choice between migration and
duplication. While chemotaxis and durotaxis are detailed
by Brabek et al. [4], the role of a pro-oxidant and/or low
oxygen environment in the regulation of cell motility has
been recently reviewed by Pani and Chiarugi [15].
Far from being exhaustive, this special issue focused
on cell motility aims to underscore the fertility of the
current research efforts in this field, as well as highlight-
ing key questions that still are awaiting definitive
answers.
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